UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to section 13 or 15(d) of
the Securities exchange act of 1934
Date of Report (Date of earliest event reported): January 20, 1997
MERIS LABORATORIES, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
California
- --------------------------------------------------------------------------------
(State or other jurisdiction of incorporation or organization)
0-19360 77-0274078
- --------------------------- ------------------------------------------
(Commission file number) (I.R.S. Employer Identification No.)
2890 Zanker Road, San Jose, California 95134
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 408-434-9200
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
1
<PAGE>
Item 5. Other Events
Effective January 20, 1997, the Company's common stock has been de-listed
from the Nasdaq National Market due to its inability to meet certain Nasdaq
minimum listing requirements. As a result, Nasdaq will notify the market makers
that the Company's common stock has defaulted into the National Association of
Securities Dealers, Inc. (NASD) OTC Bulletin Board where it may be traded. (See
Exhibit A for the press release issued for this event.)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MERIS LABORATORIES, INC.
By: /s/ Thurman Jordan
--------------------------------------
Thurman Jordan
Senior Vice President - Finance
(Duly authorized Officer and Principal
Financial and Accounting Officer)
Date: January 21, 1997
2
<PAGE>
EXHIBIT A
FOR IMMEDIATE RELEASE
- --------------------- Contact: William McCormick
President & CEO
(408) 434-9200 x3710
Thurman Jordan
Senior Vice President,
Finance and CFO
(408) 434-9200 x3722
MERIS LABORATORIES, INC. ANNOUNCES ITS
COMMON STOCK DE-LISTED FROM NASDAQ NATIONAL MARKET
San Jose, CA., January 20, 1997 - Meris Laboratories, Inc. (Nasdaq - MERS)
announced that, effective today, its common stock has been de-listed from the
Nasdaq National Market due to its inability to meet certain Nasdaq minimum
listing requirements. As a result, Nasdaq will notify the market makers that the
Company's common stock has defaulted into the National Association of Securities
Dealers, Inc. (NASD) OTC Bulletin Board where it may be traded.
# # #
3
